Sort
82,697 grants matching “vaccine development”
Statistical Methods for Evaluating and Guiding Implementation of New HIV Prevention Strategies
$774,818Holly Janes · Fred Hutchinson Cancer Research Center · R56 · FY2019 · AI
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses
$774,808Mayumi Nakagawa · Univ Of Arkansas For Med Scis · R01 · FY2010 · CA
Vaccine and Monoclonal Antibody Studies in HIV-infected Subjects
$774,746Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Vaccine and Monoclonal Antibody Studies in HIV-infected Subjects
$774,746Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Engineered, multispecific antibodies as broad anti-filovirus therapeutics
$774,730Jonathan R. Lai · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
Evaluation of Smoke-Free Housing Policy Impacts on Tobacco Smoke Exposure and Health Outcomes
$774,729Lorna Thorpe · New York University School Of Medicine · R01 · FY2020 · CA
Adenovirus and Poxvirus Mediated Protection Against Mucosal SIV Infection
$774,710Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2015 · AI
Drivers of strain-specific and strain-transcendent antimalarial immunity in childhood
$774,583Bryan R Greenhouse · University Of California, San Francisco · R01 · FY2024 · AI
Vector Production Core
$774,582Norman L Letvin · Duke University · U19 · FY2009 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$774,571Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2024 · AI
Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS
$774,538Theodora Hatziioannou · Aaron Diamond Aids Research Center · R01 · FY2014 · AI
Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS
$774,538Theodora Hatziioannou · Aaron Diamond Aids Research Center · R01 · FY2015 · AI
Sex determination and the sex-determining locus in aedine mosquitoes
$774,520Zhijian Jake Tu · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · AI
SERCEB Individual Career Development Support Program
$774,499Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2010 · AI
Immunotherapeutics Against Arenaviruses
$774,498Robert F Garry · Scripps Research Institute, The · U19 · FY2015 · AI
Physical Resources Core
$774,432Justin Joseph Pollara · Duke University · P01 · FY2023 · AI
HIV-1 vaccine-elicited antibodies target envelope glycans
$774,421Kevin O Saunders · Duke University · R01 · FY2022 · AI
Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis
$774,416Rebecca M. Brotman · University Of Maryland Baltimore · R01 · FY2023 · AI
Antibody-based countermeasures against fentanyl and its analogues
$774,408Marco Pravetoni · University Of Washington · U01 · FY2022 · DA
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis
$774,335Alessandro Grattoni · Methodist Hospital Research Institute · R01 · FY2017 · AI
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
$774,283Christopher L King · Case Western Reserve University · R01 · FY2020 · AI
Natural history, immunity, and transmission patterns of sapovirus in a Nicaraguan birth cohort
$774,235Sylvia Irene Becker-Dreps · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Cytokines in AIDS and Cancer
$774,189George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The effect of binding of fH to meningococcal fHbp vaccine on antibody protection
$774,128Dan M. Granoff · Children'S Hospital & Res Ctr At Oakland · R01 · FY2016 · AI
Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2
$774,037Kyeong-Ok Chang · Kansas State University · R01 · FY2021 · AI